EXTRAPOLATING IN VITRO DATA ON DRUG METABOLISM TO IN VIVO PHARMACOKINETICS: EVALUATION OF THE PHARMACOKINETIC INTERACTION BETWEEN AMITRIPTYLINE AND FLUOXETINE

REFERENCES

• Wilkinson G. R. Clearance approaches in pharmacology. Pharmacol. Rev. 1987; 39: 1–47
   PubMed Web of Science ®Google Scholar
• Schmider J., Greenblatt D. J., von Moltke L. L., Harmatz J. S., Shader R. I. Metabolism of amitriptyline by human liver microsomes; identification of cytochrome P450 enzymes involved. Pharmacopsychiatry 1997; 30: 219
   Google Scholar
• Andersson T., Miners J. O., Veronese M. E., Birkett D. J. Diazepam metabolism by human liver microsomes is mediated by both S-mephenytoin hydroxylase and CYP3A isoforms. Br. J. Clin. Pharmacol. 1994; 38: 131–137
   PubMed Web of Science ®Google Scholar
• Schmider J., Greenblatt D. J., von Moltke L. L., Shader R. I. Relationship of in vitro data on drug metabolism to in vivo pharmacokinetics and drug interactions; implications for diazepam disposition in humans. J. Clin. Psychopharmacol 1996; 16: 267–272
   PubMed Web of Science ®Google Scholar
• von Moltke L. L., Greenblatt D. J., Harmatz J. S., Duan S. X., Harrel L. M., Cotreau-Bibbo M. M., Pritchard G. A., Wright C. E., Shader R. I. Triazolam biotransformation by human liver microsomes in vitro: Effects of metabolic inhibitors and clinical confirmation of a predicted interaction with ketoconazole. J. Pharmacol. Exp. Ther. 1996; 276: 370–379
   PubMed Web of Science ®Google Scholar
• von Moltke L. L., Greenblatt D. J., Cotreau-Bibbo M. M., Harmatz J. S., Shader R. I. Inhibitors of alprazolam metabolism in vitro: Effect of serotonin-reuptake-inhibitor antidepressants, ketoconazole and quinidine. Br. J. Clin. Pharmacol. 1994; 38: 23–31
   PubMed Web of Science ®Google Scholar
• Schmider J., Greenblatt D. J., Harmatz J. S., Shader R. I. Enzyme kinetic modelling as a tool to analyse the behaviour of cytochrome P450 catalysed reactions: Application to amitriptyline N-demethylation. Br. J. Clin. Pharmacol 1996; 41: 593–604
   PubMed Web of Science ®Google Scholar
• von Moltke L. L., Greenblatt D. J., Schmider J., Harmatz J. S., Shader R. I. Metabolism of drugs by cytochrome P450 3A isoforms. Clin. Pharmacokinet. 1995; 29(Suppl. 1)33–43
   PubMedGoogle Scholar
• Schmider J., Greenblatt D. J., Fogelman S. M., von Moltke L. L., Shader R. I. Metabolism of dextromethorphan in vitro: Involvement of cytochromes P450 2D6, 3A3/4, with a possible role of 2E1. Biopharm. Drug. Dispos. 1997; 18: 227–240
   PubMed Web of Science ®Google Scholar
• Schmider J., Greenblatt D. J., von Moltke L. L., Harmatz J. S., Shader R. I. Inhibition of cytochrome P450 by nefazodone in vitro: studies of dextromethorphan O- and N-demethylation. Br. J. Clin. Pharmacol 1996; 41: 339–343
   PubMed Web of Science ®Google Scholar
• Schmider J., Greenblatt D. J., von Moltke L. L., Karsov D., Shader R. I. Inhibition of CYP2C9 by selective serotonin reuptake inhibitors in vitro: studies of phenytoin 4-hydroxylation. Br. J. Clin. Pharmacol xs1997; 44: 495–498
   PubMed Web of Science ®Google Scholar
• Schmider J., Greenblatt D. J., von Moltke L. L., Karsov D., Vena R., Friedman H. L., Shader R. I. Biotransformation of mestranol to ethinyestradiol in vitro: the role of cytochrome P450 2C9 and metabolic inhibitors. J. Clin. Pharmacol 1997; 37: 193–200
   PubMed Web of Science ®Google Scholar
• Schmider J., Greenblatt J. D., von Moltke L. L., Harmatz J. S., Duan S. X., Karsov D., Shader R. I. Characterization of six in vitro reactions mediated by human cytochrome P450: application to the testing of cytochrome P450-directed antibodies. Pharmacology 1996; 52: 125–134
   PubMed Web of Science ®Google Scholar
• von Moltke L. L., Greenblatt D. J., Duan S. X., Schmider J., Kudchadker L., Fogelman S. M., Harmatz J. S., Shader R. I. Phenacetin O-deethylation by human liver microsomes in vitro: inhibition by chemical probes, SSRI antidepressants, nefazodone, and venlafaxine. Psychopharmacology 1996; 128: 398–407
   PubMed Web of Science ®Google Scholar
• von Moltke L. L., Greenblatt D. J., Duan S. X., Schmider J., Wright C. E., Harmatz J. S., Shader R. I. Human cytochromes mediating N-demethylation of fluoxetine in vitro. Psychopharmacology 1997; 132: 402–407
   PubMed Web of Science ®Google Scholar
• von Moltke L. L., Greenblatt D. J., Schmider J., Duan S. X., Wright C. E., Harmatz J. S., Shader R. I. Midazolam hydroxylation by human liver microsomes in vitro: Inhibition by fluoxetine, norfluoxetine, and by azole antifungal agents. J. Clin. Pharmacol. 1996; 36: 783–791
   PubMed Web of Science ®Google Scholar
• Bailey D. N., Shaw R. F. Interpretation of blood and tissue concentrations in fatal self-ingested overdose involving amitriptyline: An update (1978–1979). J. Anal. Toxicol. 1980; 4: 232–236
   PubMed Web of Science ®Google Scholar
• Fraser A. D., Isner A. F., Perry R. A. Distribution of trimipramine and its major metabolites in a fatal overdose case. J. Anal. Toxicol. 1987; 11: 168–170
   PubMed Web of Science ®Google Scholar
• Levine B., Jenkins A. J., Smialek J. E. Distribution of sertraline in postmortem cases. J. Anal. Toxicol. 1994; 18: 272–274
   PubMed Web of Science ®Google Scholar
• Wong R. J. The determination of the triazolobenzodiazepine triazolam in post mortem samples. J. Anal. Toxicol. 1984; 8: 10–13
   PubMed Web of Science ®Google Scholar
• Kurz H., Fichtl B. Binding of drugs to tissues. Drug Metab. Rev. 1983; 14: 467–510
   PubMed Web of Science ®Google Scholar
• Pacifici G. M., Viani A. Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences. Clin. Pharmacokinet. 1992; 23: 449–468
   PubMed Web of Science ®Google Scholar
• Schuhmann G., Fichtl B., Kurz H. Prediction of drug distribution in vivo on the basis of in vitro binding data. Biopharm. Drug Dispos. 1987; 8: 73–86
   PubMed Web of Science ®Google Scholar
• Chou C. H., Evans A. M., Fornasini G., Rowland M. Relationship between lipophilicity and hepatic dispersion and distribution for a homologous series of barbiturates in the isolated perfused in situ rat liver. Drug Metab. Dispos. 1993; 21: 933–938
   PubMed Web of Science ®Google Scholar
• Igari Y., Sugiyama Y., Sawada Y., Iga T., Hanano M. Tissue distribution of 14C-diazepam and its metabolites in rats. Drug Metab. Dispos. 1982; 10: 676–679
   PubMed Web of Science ®Google Scholar
• Scavone J. M., Friedman H., Greenblatt D. J., Shader R. I. Effect of age, body composition, and lipid solubility on benzodiazepine tissue distribution in rats. Arzn. Forsch. 1996; 37: 2–6
   Google Scholar
• Greenblatt D. J., von Moltke L. L., Schmider J., Harmatz J. S., Shader R. I. Inhibition of human cytochrome P450-3A isoforms by fluoxetine and norfluoxetine: in vitro and in vivo studies. J. Clin. Pharmacol. 1996; 36: 792–798
   PubMed Web of Science ®Google Scholar
• Obach R. S. Nonspecific binding to microsomes: impact on scale-up of in vitro intrinsic clearance to hepatic clearance as assessed through examination of warfarin, imipramine, and propranolol. Drug Metab. Dispos. 1997; 25: 1359–1369
   PubMed Web of Science ®Google Scholar
• Müller N., Brockmöller J., Roots I. Extremely long plasma half-life of amitriptyline in a woman with the cytochrome P450IID6 29/29-kilobase wild-type allele—a slowly reversible interaction with fluoxetine. Ther. Drug Monit. 1991; 13: 533–536
   PubMed Web of Science ®Google Scholar
• Vandel S., Bertschy G., Bonin B., Nezelof S., Francois T. H., Vandel B., Sechter D., Bizouard P. Tricyclic antidepressant plasma levels after fluoxetine addition. Neuropsychobiology 1992; 25: 202–207
   PubMed Web of Science ®Google Scholar
• Rollins D. E., Alvan G., Bertilsson L., Gillette J. R., Mellstrom B., Sjoqvist F., Traskman L. Interindividual differences in amitriptyline demethylation. Clin. Pharmacol. Ther. 1980; 28: 121–129
   PubMed Web of Science ®Google Scholar
• Ghahramani P., Ellis S. W., Lennard M. S., Ramsay L. E., Tucker G. T. Cytochromes p450 mediating the N-demethylation of amitriptyline. Br. J. Clin. Pharmacol. 1997; 43: 137–144
   PubMed Web of Science ®Google Scholar
• Schmider J., Greenblatt D. J., von Moltke L. L., Harmatz J. S., Shader R. I. N-demethylation of amitriptyline in vitro: Role of cytochrome P-450 3A (CYP3A) isoforms and effect of metabolic inhibitors. J. Pharmacol. Exp. Ther. 1995; 275: 592–597
   PubMed Web of Science ®Google Scholar
• Venkatakrishnan K., Greenblatt D. J., von Moltke L. L., Schmider J., Harmatz J. S., Shader R. I. Five distinct human cytochromes mediate amitriptyline N-demethylation in vitro: Dominance of CYP2C19 and 3A4. J. Clin. Pharmacol. 1998; 38: 112–121
   PubMed Web of Science ®Google Scholar
• Olesen O. V., Linnet K. Metabolism of the tricyclic antidepressant amitriptyline by cDNA-expressed human cytochrome P450 isozymes. Pharmacology 1997; 55: 235–243
   PubMed Web of Science ®Google Scholar
• Baumann P., Jonzier-Perey M., Koeb L., Kupfer A., Tinguely D., Schopf J. Amitriptyline pharmacokinetics and clinical response: II. Metabolic polymorphism assessed by hydroxylation of debrisoquine and mephenytoin. Int. Clin. Psychopharmacol. 1986; 1: 102–112
   PubMed Web of Science ®Google Scholar
• Breyer-Pfaff U., Pfandl B., Nill K., Nusser E., Monney C., Jonzier-Perey M., Baettig D., Baumann P. Enantioselective amitriptyline metabolism in patients phenotyped for two cytochrome P450 isozymes. Clin. Pharmacol. Ther. 1992; 52: 350–358
   PubMed Web of Science ®Google Scholar
• Lemberger L., Bergstrom R. F., Wolen R. L., Farid N. A., Enas G. G., Aronoff G. R. Fluoxetine: Clinical pharmacology and physiologic disposition. J. Clin. Psychiatry 1985; 46(3 Pt. 2)14–19
   PubMed Web of Science ®Google Scholar
• van Harten J. Clinical pharmacokinetics of selective serotonin reuptake inhibitors. Clin. Pharmacokinet 1993; 24: 203–220
   PubMed Web of Science ®Google Scholar
• Crewe H. K., Lennard M. S., Tucker G. T., Woods F. R., Haddock R. E. The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes. Br. J. Clin. Pharmacol. 1992; 34: 262–265
   PubMed Web of Science ®Google Scholar
• Otton S. V., Wu D., Joffe R. T., Cheung S. W., Sellers E. M. Inhibition by fluoxetine of cytochrome P450 2D6 activity. Clin. Pharmacol. Ther. 1993; 53: 401–409
   PubMed Web of Science ®Google Scholar
• Preskorn S. H., Alderman J., Chung M., Harrison W., Messig M., Harris S. Pharmacokinetics of desipramine coadministered with sertraline or fluoxetine. J. Clin. Psychopharmacol. 1994; 14: 90–98
   PubMed Web of Science ®Google Scholar
• Wright C. E., Lasher-Sisson T. A., Steenwyk R. C., Swanson C. N. A pharmacokinetic evaluation of the combined administration of triazolam and fluoxetine. Pharmacotherapy 1992; 12: 103–106
   PubMed Web of Science ®Google Scholar
• von Moltke L. L., Greenblatt D. J., Cotreau-Bibbo M. M., Duan S. X., Harmatz J. S., Shader R. I. Inhibition of desipramine hydroxylation in vitro by serotonin-reuptake-inhibitor antidepressants, and by quinidine and ketoconazole: A model system to predict drug interactions in vivo. J. Pharmacol. Exp. Ther. 1994; 268: 1278–1283
   PubMed Web of Science ®Google Scholar
• El-Yazigi A., Chaleby K., Gad A., Raines D. A. Steady-state kinetics of fluoxetine and amitriptyline in patients treated with a combination of these drugs as compared with those treated with amitriptyline alone. J. Clin. Pharmacol. 1995; 35: 17–21
   PubMed Web of Science ®Google Scholar
• von Moltke L. L., Greenblatt D. J., Duan S. X., Harmatz J. S., Harmatz R. I. In vitro prediction of the terfenadine-ketoconazole pharmacokinetic interaction. J. Clin. Pharmacol. 1994; 34: 1222–1227
   PubMed Web of Science ®Google Scholar
• von Moltke L. L., Greenblatt D. J., Duan S. X., Harmatz J. S., Wright C. E., Shader R. I. Inhibition of terfenadine metabolismin vitro by azole antifungal agents and by selective serotonin reuptake inhibitor antidepressants: Relation to phamacokinetic interactionsin vivo. J. Clin. Psychopharmacol. 1996; 36: 104–113
   Google Scholar
• von Moltke L. L., Greenblatt D. J., Schmider J., Wright C. E., Harmatz J. S., Shader R. I. In vitro approaches to predicting drug interactions in vivo. Biochem. Pharmacol. 1997; 55: 113–122
   Web of Science ®Google Scholar